Next-gen therapies for cancer, dementia and more fast-tracked with new facility

Office for Artificial Intelligence UK Published: 2025-08-28 08:00:02

A new facility in Darlington is being established to develop innovative RNA therapies for cancer, heart conditions, infectious diseases, and other health issues. The facility is expected to serve as a launching pad for cutting-edge treatments that target a variety of medical conditions.

Full text

New facility based in Darlington to springboard novel RNA therapies – which could help tackle cancer, heart conditions, infectious diseases, and more.

Open Source →

Recommended reads

Notice: UK-Germany joint statement on advanced AI safety and security From UK

A joint statement by the UK and Germany on collaborating to ensure advanced AI is developed safely and its risks are rigorously understood and managed.

Office for Artificial Intelligence · UK 2026-06-30

Guidance: Person Data Standard: overview and guidance From UK

Learn about the Alpha Person Data Standard and how to provide feedback.

Office for Artificial Intelligence · UK 2026-06-30

Guidance: Person Standard Use Case: HMPPS Core Person Service From UK

Learn how the Person Data Standard can be applied in practice when a single authoritative identity is required for person data.

Office for Artificial Intelligence · UK 2026-06-30